Published in Neurology on March 01, 1996
Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation. Protein Sci (2006) 1.07
Early onset prion disease from octarepeat expansion correlates with copper binding properties. PLoS Pathog (2009) 1.03
Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathol (2010) 0.99
The octarepeat region of the prion protein is conformationally altered in PrP(Sc). PLoS One (2010) 0.87
Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem (2008) 0.86
Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. Arch Neurol (2011) 0.82
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases. Acta Neuropathol Commun (2013) 0.76
Hereditary Human Prion Diseases: an Update. Mol Neurobiol (2016) 0.76
A case of Gerstmann-Sträussler-Scheinker disease with a novel six octapeptide repeat insertion. Neuropathol Appl Neurobiol (2011) 0.76
Prion protein self-peptides modulate prion interactions and conversion. BMC Biochem (2009) 0.76
The crystal structure of an octapeptide repeat of the prion protein in complex with a Fab fragment of the POM2 antibody. Protein Sci (2013) 0.75
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
The same prion strain causes vCJD and BSE. Nature (1997) 12.49
A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature (1990) 10.97
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature (1991) 5.04
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet (2004) 4.85
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet (1997) 4.28
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet (1992) 3.74
Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet (1999) 3.39
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet (1991) 3.22
Corticobasal degeneration. Brain (1989) 3.20
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature (1996) 3.09
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 3.03
Creutzfeldt-Jakob disease and blood transfusion. Lancet (1993) 2.97
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (2000) 2.92
Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol (1994) 2.88
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A (1994) 2.70
Prion protein is necessary for normal synaptic function. Nature (1994) 2.69
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry (1984) 2.68
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis (2001) 2.62
Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol (1999) 2.61
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A (2000) 2.50
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry (2010) 2.29
Research diagnostic criteria for Parkinson's disease. Adv Neurol (1990) 2.28
Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J (2002) 2.26
Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci U S A (2001) 2.16
Post-exposure prophylaxis after accidental prion inoculation. Lancet (1997) 2.15
Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1982) 2.15
Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet (1989) 2.11
Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04
Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology (2006) 2.00
Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet (2001) 1.97
Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A (2001) 1.96
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry (1989) 1.95
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science (1999) 1.95
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain (1992) 1.86
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84
Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet (1995) 1.78
Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet (1995) 1.76
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang (2006) 1.76
Molecular screening of sheep for bovine spongiform encephalopathy. Neurosci Lett (1998) 1.74
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2002) 1.72
Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology (2003) 1.71
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70
Amount of research interest in rare and common neurological conditions: bibliometric study. BMJ (2001) 1.68
Transmission of scrapie by steel-surface-bound prions. Mol Med (2001) 1.63
Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol (1990) 1.63
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet (1990) 1.52
Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet (1993) 1.52
Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology (1994) 1.50
Sporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet (2001) 1.50
Lymphocyte contamination of laryngoscope blades--a possible vector for transmission of variant Creutzfeldt-Jakob disease. Anaesthesia (2005) 1.45
Variant CJD and blood transfusion: are there additional cases? Vox Sang (2014) 1.42
Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet (1999) 1.42
Risk factors for variant Creutzfeldt-Jakob disease in dental practice: a case-control study. Br Dent J (2012) 1.42
Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat Struct Biol (1999) 1.41
Vaccines and variant CJD. Vaccine (2000) 1.40
Codon 129 genotype and new variant CJD. Lancet (1997) 1.40
Monoclonal antibodies against the complement control protein factor H (beta 1 H). Biosci Rep (1983) 1.40
Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease. AJNR Am J Neuroradiol (2013) 1.39
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet (1996) 1.37
Transmission of fatal familial insomnia to laboratory animals. Lancet (1995) 1.37
Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet (1996) 1.36
Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology (2000) 1.34
Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study. Lancet (2000) 1.34
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases. N Engl J Med (1985) 1.32
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.30
Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain (2008) 1.30
MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol (2001) 1.30
Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett (1996) 1.29
Multiple folding pathways for heterologously expressed human prion protein. Biochim Biophys Acta (1999) 1.29
Crystal structure of human prion protein bound to a therapeutic antibody. Proc Natl Acad Sci U S A (2009) 1.29
Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. BMJ (1997) 1.27
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979. II: Epidemiology. J Neurol Neurosurg Psychiatry (1986) 1.25